Literature DB >> 29933491

Treatment for Lexical Retrieval Impairments in Primary Progressive Aphasia: A Research Update with Implications for Clinical Practice.

Karen Croot1,2.   

Abstract

Lexical retrieval impairments (also known as anomia or word-finding deficits) are an early and prominent symptom in primary progressive aphasia (PPA), causing distress and frustration to individuals with PPA and their communication partners, and prompting research on lexical retrieval treatment. This paper reviews the research on lexical retrieval treatment in PPA from the earliest reports in the 1990s to early 2018 and considers the implications of this research for clinical practice. The number of published studies has increased markedly over the past decade, consisting primarily of behavioral studies, with rapid recent growth in noninvasive brain stimulation studies. Five general treatment techniques were identified in the behavioral studies, described here as standard naming treatment, Look, Listen, Repeat treatment, cueing hierarchies, semantically focused treatments, and lexical retrieval in context. Across techniques, behavioral studies targeting difficult-to-retrieve items typically report immediate gains, and there is evidence these gains can be maintained over months to years by some participants who continue with long-term treatment. There is also evidence that prophylactic treatment supports retrieval of treated items compared with untreated items. There is limited evidence for generalization of treatment to untreated items, suggesting the primary aim of lexical retrieval treatment in this population is to maintain retrieval of a core vocabulary for as long as possible. Language and cognitive assessment and piloting of the intended treatment can inform decisions about treatment selection and participant suitability for long-term lexical retrieval treatment. The paper concludes with some questions to guide clinical decision making about whether to implement or continue with a behavioral lexical retrieval treatment. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2018        PMID: 29933491     DOI: 10.1055/s-0038-1660783

Source DB:  PubMed          Journal:  Semin Speech Lang        ISSN: 0734-0478            Impact factor:   1.761


  6 in total

Review 1.  Primary progressive aphasia: a model for neurodegenerative disease.

Authors:  Boon Lead Tee; Maria Luisa Gorno-Tempini
Journal:  Curr Opin Neurol       Date:  2019-04       Impact factor: 5.710

2.  Communication Partner Engagement: A Relevant Factor for Functional Outcomes in Speech-Language Therapy for Aphasic Dementia.

Authors:  Emily Rogalski; Angela Roberts; Elizabeth Salley; Marie Saxon; Angela Fought; Marissa Esparza; Erin Blaze; Christina Coventry; Marek-Marsel Mesulam; Sandra Weintraub; Aimee Mooney; Becky Khayum; Alfred Rademaker
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2022-06-01       Impact factor: 4.942

Review 3.  A Scoping Review of Cognitive Training in Neurodegenerative Diseases via Computerized and Virtual Reality Tools: What We Know So Far.

Authors:  Stefano Lasaponara; Fabio Marson; Fabrizio Doricchi; Marco Cavallo
Journal:  Brain Sci       Date:  2021-04-21

4.  Treatment for Anomia in Bilingual Speakers with Progressive Aphasia.

Authors:  Stephanie M Grasso; Elizabeth D Peña; Nina Kazemi; Haideh Mirzapour; Rozen Neupane; Borna Bonakdarpour; Maria Luisa Gorno-Tempini; Maya L Henry
Journal:  Brain Sci       Date:  2021-10-20

5.  A Systematic Review of Transcranial Direct Current Stimulation in Primary Progressive Aphasia: Methodological Considerations.

Authors:  Silke Coemans; Esli Struys; Dorien Vandenborre; Ineke Wilssens; Sebastiaan Engelborghs; Philippe Paquier; Kyrana Tsapkini; Stefanie Keulen
Journal:  Front Aging Neurosci       Date:  2021-10-07       Impact factor: 5.750

Review 6.  Language training for oral and written naming impairment in primary progressive aphasia: a review.

Authors:  Ilaria Pagnoni; Elena Gobbi; Enrico Premi; Barbara Borroni; Giuliano Binetti; Maria Cotelli; Rosa Manenti
Journal:  Transl Neurodegener       Date:  2021-07-16       Impact factor: 8.014

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.